Fluorescence in situ hybridisation analysis of sex chromosome in non-obstructive azoospermic men



genetic epilepsy syndromes :: Article Creator

Gene Therapy For Rare Epilepsy Shows Promise In Mice

Just a moment...

This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation!

Press and Hold

Press and hold the button

If you believe this is an error, please contact our support team.

167.71.87.121 : 8e5aaf64-c228-4453-a14d-a0583483


Dallas Researchers Work To Unravel The Mystery Of Sudden Unexpected Death In Epilepsy

New findings from a lab of an SMU biology professor have provided valuable clues in unraveling the mystery of sudden unexpected death in epilepsy (SUDEP), the leading cause of epilepsy-related mortality.

The underlying mechanisms behind SUDEP historically have been shrouded in mystery but work in Edward Glasscock's lab is helping to pull back the curtain, SMU said.

SMU said that roughly 3 million people in the U.S. Have epilepsy, making it the country's fourth most common neurological disease; SUDEP claims more lives in the United States every year than the more widely publicized sudden infant death syndrome (SIDS).

The university said that in new research published in the journal Brain Communications, Kelsey Paulhus, a post-doctoral researcher in the Glasscock lab and lead author of the study, shows that excitatory neurons within the brain's corticolimbic circuits have a prominent role to play in epilepsy and SUDEP.

A missing key protein

The researchers' findings are the first to show that circuits lacking a specific protein, Kv1.1, in this subset of neurons promote seizures that can lead to lethal cardiorespiratory failure.

"For a long time, SUDEP has been suspected to involve a fatal breakdown in communication between the brain, heart, and lungs." Paulhus said. "In this study, we actually observed this breakdown in real time using simultaneous recordings of brain, heart, and lung activity in mice without Kv1.1 in select brain circuits."

The lab's work is moving researchers closer to improved treatments.

"Identifying specific proteins and brain circuits involved in SUDEP moves us closer to developing interventions that may prevent this tragic epilepsy-related outcome," said Vicky Whittemore, program director at the NIH's National Institute of Neurological Disorders and Stroke, which funded the study.

"Given the unpredictable nature of SUDEP, observing the physiological mechanisms associated with lethal seizures is challenging and has only been accomplished experimentally a handful of times worldwide," Glasscock said in a statement. "Therefore, this work provides a rare glimpse into the potential sequence of events that lead to sudden death in epilepsy."

The Kv1.1 protein investigated in the study is encoded by the Kcna1 gene and belongs to a family of voltage-gated potassium channels known for their role in controlling signals in and between brain and heart cells. Mutations in Kcna1 are a common genetic cause of epilepsy in people. More severe mutations can lead to epileptic encephalopathy, an especially severe form of epilepsy associated with an increased risk of SUDEP.

SMU said that that the corticolimbic circuit, which is part of the forebrain, holds significant regulatory power over the heart and lung functions, even though the brainstem often is thought of as the place where the body regulates their functions. In addition to being a frequent seizure onset zone, this circuit, which includes the cortex, hippocampus, and amygdala, also is important for learning and memory function, the university said.

In people with epilepsy, seizures or direct simulation of the amygdala and/or hippocampus can pause breathing and impair heart function suddenly and without warning, possibly increasing the chances of sudden death when seizures invade these brain structures.

Tagging 'a significant genetic risk'

SMU said that in another recent paper from the Glasscock lab in the Journal of General Physiology, post-doctoral fellow Man Si and colleagues investigated the role of Kv1.1 in cardiac pacemaker cells in the heart's sinoatrial node, a patch of cells located along the upper wall of the right atrium.

Researchers said those cells generate electrical impulses that start every heartbeat.

Using mice, Si discovered that when Kv1.1 is missing or blocked, pacemaker cells have difficulty in maintaining normal electrical activity resulting in abnormal heart rhythms.

"Given the importance of Kv1.1 in maintaining proper brain and heart function, mutations affecting this protein could represent a significant genetic risk factor for SUDEP," Glasscock said.

Ultimately, SMU said that study and the one published in Brain Communications, suggests Kv1.1 is a significant research target to uncover the complex multi-organ causes of SUDEP.

The university said that these studies are part of Glasscock's ongoing research funded by the National Institutes of Health. Glasscock is the Prothro Distinguished Chair of Biological Sciences in SMU's Dedman College of Humanities and Sciences.

Paulhus' research also was supported by a predoctoral fellowship from the American Epilepsy Society. She also was a part of the Journal of General Physiology study, as were SMU's Man Si and Praveen Kumar; Northwestern State's Ahmad Darvish; and Louisiana State University Health Sciences Center's Kathryn Hamilton.

Track Dallas-Fort Worth's business and innovation landscape with our curated news in your inbox Tuesday-Thursday.

R E A D   N E X T
  • New architectural renderings by the Copenhagen-based Bjarke Ingels Group "reflects the resilience and richness of African American culture and aims to foster education, growth, and connection within the community," the museum said.

  • Premature babies diagnosed with bronchopulmonary dysplasia (BPD) face the risk of rehospitalization, delayed brain development, and respiratory problems throughout childhood. No FDA-approved therapies are available for BPD—which is why the new FDA designation for AyuVis's drug candidate, AVR-48, could lead to game-changing impact.

  • Aiming to safeguard national security using advanced AI, cybersecurity experts at the University of North Texas have received $3 million from the Department of Defense to help the department overhaul its hiring processes. The UNT researchers, led by computer science and engineering faculty Ram Dantu and Cihan Tunc, received $2.1 million in funding from the Cyber Service Academy under the DOD's chief information officer. The rest of the funds came from the National Security Agency. "This is about ensuring we have the right people in the right positions to protect our national security. There are so many foreign actors working…

  • New York-based Local Projects said it will design immersive, interactive exhibitions for the museum featuring multimedia installations and historical artifacts, with an aim of "fostering a powerful connection between visitors and the story and impact of Juneteenth."

  • The project, led by Assistant Professor of Biology Alicia Rogers, could lead to improved genetic knowledge that may aid in the development of synthetic therapies to prevent or treat diseases, including cancer.


  • A New Gene Therapy For Children With Dravet Syndrome Developed

    New Delhi: A team of researchers has developed a new gene therapy for children with Dravet syndrome - a rare type of epilepsy in children.

    Dravet syndrome (DS) is a developmental and epileptic encephalopathy (DEE) that begins in the first year of life. The condition is rare but devastating and causes a host of symptoms in children, including seizures, intellectual disability, and even sudden death. A DEE causes developmental slowing or regression, while most patients have seizures that occur on a background of developmental delay. As most cases are caused by a genetic mutation; researchers from the University of Michigan focussed on the SCN1B gene - which plays a role in regulating sodium channels in the brain and heart.

    The gene causes an even more severe form of DEE. In the mice study, the team found that without the SCN1B gene, the animals experienced seizures and 100 per cent mortality just three weeks after birth. The team tested a gene therapy in mice models to replace SCN1B to increase the expression of beta-1 protein -- necessary for the regulation of sodium channels in the brain.

    The therapy in newborn mice increased their survival, reduced the severity of their seizures, and restored brain neuron excitability.

    "Different forms of SCN1B gene expression may result in different outcomes for the therapy. However, the proof-of-concept is the first step toward a gene replacement therapy for SCN1B-linked developmental and epileptic encephalopathy," said the team in the paper published in the Journal of Clinical Investigation. A recent study, detailed in the journal Neurology, showed that epilepsy and developmental impairment before the age of 16 years occurs in 1 in 340 children, with 1 in 590 having a DEE and 1 in 800 having intellectual disability and epilepsy.






    Comments

    Popular posts from this blog

    Well-liked Medicare plan vs. higher-ranked providers - ChicagoNow

    Minnesota veterans blame 3M's 'defective' ear plugs for hearing damage - KSTP

    Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield | European Journal of Human Genetics